BJUI Mini Reviews - Chemotherapy for advanced adrenal cancer: Improvement from a molecular approach?

BERKELEY, CA (UroToday.com) - Adrenocortical carcinoma (ACC) is one of the uncommon malignancies.

Worldwide, the annual incidence is only 1 – 2 per million.[ 1 ] In the USA, it is estimated that ≈ 300 cases of ACC occur per year.[ 1 ] There is a slight predominance in women and the female: male ratio is approximately 4:3.[ 2,3 ] A bimodal age distribution has been reported, with the first peak occurring before age 5, and the second one in the fourth to fifth decades. Geographical factors may also play a role. A higher incidence of ACC is found in certain regions, such as in southern and southwestern Brazil. This distribution may be related to rates of sporadic mutations such as the TP 53 tumour suppressor gene.[ 4,5 ]...View or save the full text Mini Review as a .pdf file

 


Renata Costa , Robert Wesolowski and Derek Raghavan *

Cleveland Clinic Taussig Cancer Institute, Ohio State University James Cancer Institute, Columbus, OH, and * Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA

 



More BJUI Mini Reviews and Archives

 

UroToday.com Adrenal and Retroperitoneum Section



 

 

{tortags,47638,1}